GRAIL Appoints Chairman Bill Rastetter to Chief Executive Officer
02 août 2017 14h00 HE
|
Grail, Inc.
Founding CEO Jeff Huber Appointed Vice Chairman of the Board of Directors Ken Drazan Promoted to President MENLO PARK, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- GRAIL, Inc., a life sciences...
GRAIL Announces Data From Early Research Analyzing its High-Intensity Sequencing Approach
03 juin 2017 07h30 HE
|
Grail, Inc.
CHICAGO, June 03, 2017 (GLOBE NEWSWIRE) -- GRAIL, Inc., a life sciences company focused on the early detection of cancer, today announced results from a study evaluating a novel high-intensity...
GRAIL与Cirina(思为诺)合并创建专注于早期癌症诊断与筛查的全球公司
31 mai 2017 20h00 HE
|
Grail, Inc.
加利福尼亚州门洛帕克及香港, June 01, 2017 (GLOBE NEWSWIRE) -- GRAIL, Inc.，一家以在早期可治愈阶段诊断和筛查癌症为使命的生命科学公司，今天宣布与早期测试癌症公司Cirina, Ltd., 达成合并最终协议。Cirina,...
GRAIL and Cirina Combine to Create Global Company Focused on Early Detection of Cancer
31 mai 2017 07h00 HE
|
Grail, Inc.
MENLO PARK, Calif., and HONG KONG, May 31, 2017 (GLOBE NEWSWIRE) -- GRAIL, Inc., a life sciences company whose mission is to detect cancer early when it can be cured, today announced it has entered...
GRAIL與Cirina合併，以創建一家專注於癌症早期測試的環球公司
31 mai 2017 07h00 HE
|
Grail, Inc.
加州門洛帕克和香港, May 31, 2017 (GLOBE NEWSWIRE) -- GRAIL, Inc, 一家以早期測試癌症為治愈指標的生命科學公司，今天宣佈與早期測試癌症私營公司Cirina, Ltd., 達成合併最終協議。Cirina 創辦人包括世界領先非創傷性臨床診斷的分子生物科學家盧煜明 Dennis Lo，及其香港中文大學（CUHK）同事趙慧君Rossa Chiu 和...
GRAIL Announces Board of Directors Appointments
04 mai 2017 09h00 HE
|
Grail, Inc.
MENLO PARK, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- GRAIL, Inc., a life sciences company whose mission is to detect cancer early when it can be cured, today announced the appointment of José...
GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early
20 avr. 2017 08h01 HE
|
Grail, Inc.
MENLO PARK, Calif., April 20, 2017 (GLOBE NEWSWIRE) -- GRAIL, Inc., a life sciences company whose mission is to detect cancer early when it can be cured, today announced that it has commenced its...
GRAIL Closes Over $900 Million Initial Investment in Series B Financing to Develop Blood Tests to Detect Cancer Early
01 mars 2017 08h01 HE
|
Grail, Inc.
Financing led by ARCH Venture Partners with the largest investment by Johnson & Johnson Innovation; includes additional strategic industry and venture investors GRAIL plans a second close with...
GRAIL Announces Circulating Cell-free Genome Atlas (CCGA) Study as Foundation for Development of Blood Test to Detect Cancer Early
01 déc. 2016 08h00 HE
|
Grail, Inc.
- GRAIL to Apply High-Intensity Sequencing on an Unprecedented Scale to Build an Atlas of Cancer Biology - - Initial Collaborators Include Guardian Research Network, Mayo Clinic and Hartford...